Deksametazon Pliva 4 mg tablete

Name	Deksametazon Pliva 4 mg tablete
Marketing Authorisation Number	HR-H-585079018
Active Substance	deksametazon
Composition	svaka tableta sadrži 4 mg deksametazona
Pharmaceutical Form	Tableta
Manufacturer	Merckle GmbH, Blaubeuren, Baden-Wuerttemberg, Njemačka
Marketing Authorisation Holder	Pliva Hrvatska d.o.o., Prilaz baruna Filipovića 25, Zagreb, Hrvatska
Marketing Authorisation Date	13.12.2021
MA Period of Validity	13.12.2026
Classification Number	UP/I-530-09/21-01/61
Registration Number	381-12-01/154-21-04
Prescription	Medicinal product subject to medical prescription
Type of prescription	ograničeni recept
Distribution	Supply through pharmacies (community)
Advertising to general public	not allowed
ATC Code	H02AB02
Marketing status	stavljeno u promet
Shortage status	nema nestašice
SmPC	download
PL	download
Public Assessment Report	download

Packaging description	MA Number for Packaging	Marketing status	Shortage status
20 tableta u blisteru, u kutiji	HR-H-585079018-01	stavljeno u promet	nema nestašice
50 tableta u blisteru, u kutiji	HR-H-585079018-02	nije stavljeno u promet	-
100 tableta u blisteru, u kutiji	HR-H-585079018-03	nije stavljeno u promet	-
20 tableta u blisteru, u kutiji (bolničko pakiranje)	HR-H-585079018-04	nije stavljeno u promet	-
50 tableta u blisteru, u kutiji (bolničko pakiranje)	HR-H-585079018-05	nije stavljeno u promet	-
100 tableta u blisteru, u kutiji (bolničko pakiranje)	HR-H-585079018-06	nije stavljeno u promet	-
10 tableta u blisteru, u kutiji	HR-H-585079018-07	nije stavljeno u promet	-

Medicinal Products